- Your Selections:
Refine Results
Total Results: 151
Sort by Relevance | Sorting by Date
- view as grid
- view as list
October 6, 2020
What’s the Latest on Prescription Drug Proposals from the Trump Administration, Congress, and the Biden Campaign?
Slideshow Read MoreSeptember 30, 2020
What Do We Know About Spending Related to Public Health in the U.S. and Comparable Countries?
Slideshow Read MoreSeptember 29, 2020
What Do We Know About People with High Out-of-Pocket Spending?
Slideshow Read MoreAugust 24, 2020
When Cost-Sharing Waivers for COVID-19 Treatment Expire for People with Private Insurance Plans
About 88% – nearly nine in ten – enrollees in the individual and fully-insured group markets are covered by plans that have taken action to limit out-of-pocket costs for patients undergoing treatment for COVID-19 since the start of the pandemic. However, after accounting for waivers that have already expired (20%) or are scheduled to expire by the end of September (16%), just over half of enrollees in these plans will still be eligible for waived cost-sharing in October and beyond.
Slide Read More